The store will not work correctly when cookies are disabled.
4-(4-(Hydroxymethyl)phenoxy)-N-(5-methylthiazol-2-yl)butanamide
ID: ALA4561296
PubChem CID: 155543343
Max Phase: Preclinical
Molecular Formula: C15H18N2O3S
Molecular Weight: 306.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cnc(NC(=O)CCCOc2ccc(CO)cc2)s1
Standard InChI: InChI=1S/C15H18N2O3S/c1-11-9-16-15(21-11)17-14(19)3-2-8-20-13-6-4-12(10-18)5-7-13/h4-7,9,18H,2-3,8,10H2,1H3,(H,16,17,19)
Standard InChI Key: KHQUOOYFOSJPFQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
19.0994 -4.3129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0983 -5.1325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8063 -5.5414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5160 -5.1320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5131 -4.3093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8045 -3.9041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3916 -3.9045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6840 -4.3133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9762 -3.9048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2686 -4.3136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5608 -3.9052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8531 -4.3139 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5606 -3.0880 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1453 -3.9055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0586 -3.0944 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.2592 -2.9247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8508 -3.6326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3978 -4.2396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9267 -2.1783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2243 -5.5395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2256 -6.3567 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
16 19 1 0
4 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 306.39 | Molecular Weight (Monoisotopic): 306.1038 | AlogP: 2.74 | #Rotatable Bonds: 7 |
Polar Surface Area: 71.45 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.08 | CX Basic pKa: 0.52 | CX LogP: 2.48 | CX LogD: 2.40 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.77 | Np Likeness Score: -1.52 |
References
1. Nguyen W, Jacobson J, Jarman KE, Jousset Sabroux H, Harty L, McMahon J, Lewin SR, Purcell DF, Sleebs BE.. (2019) Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models., 62 (10): [PMID:30973727] [10.1021/acs.jmedchem.9b00462] |